![](/img/cover-not-exists.png)
Nilotinib or Dasatinib Front-Line Therapy in Patients (Pts) With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP) With Pre-existing Liver and/or Renal dysfunction
Sasaki, Koji, Kantarjian, Hagop, Jabbour, Elias, Quintas-Cardama, Alfonso, Pierce, Sherry, Borthakur, Gautam, Kadia, Tapan, Pemmaraju, Naveen, Ferrajoli, Alessandra, O’Brien, Susan, Cortes, JorgeVolume:
14
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2014.06.071
Date:
September, 2014
File:
PDF, 222 KB
english, 2014